Minimal data are available regarding the pandemic’s impact on cancer screening between diverse health care settings by various screening tests, and across demographic groups. The National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium compared breast, cervical, colorectal, and lung cancer screening rates before and after the pandemic and developed recommendations including: Broader implementation of remote testing …